non-myeloablative
Showing 1 - 25 of >10,000
Sickle Cell Disease Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Non-myeloablative haploidentical
Not yet recruiting
- Sickle Cell Disease
- Non-myeloablative haploidentical peripheral blood stem celltransplantation with briquilimab and abatacept
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Dec 4, 2023
Lymphoma, Non-Hodgkin Trial in Saint Louis (Stem cell infusion, TLI, Anti-thymocyte globulin)
Active, not recruiting
- Lymphoma, Non-Hodgkin
- Stem cell infusion
- +5 more
-
Saint Louis, MissouriWashington University
Jan 17, 2023
Leukemia, Myeloid, Acute, Leukemia, Lymphoblastic, Acute, L1, Leukemia, Lymphoblastic, Acute, L2 Trial in Melbourne (Venetoclax,
Recruiting
- Leukemia, Myeloid, Acute
- +5 more
- Venetoclax
- +2 more
-
Melbourne, Victoria, AustraliaMelbourne Health
Jun 19, 2022
Mycoses, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous Trial in Stanford (anti-thymocyte globulin, cyclosporine, Lymphoid
Active, not recruiting
- Mycoses
- +5 more
- anti-thymocyte globulin
- +2 more
-
Stanford, CaliforniaStanford University School of Medicine
Jun 16, 2022
Predict T Cell Chimerism After MSD SCT for SCD?
Recruiting
- Sickle Cell Disease
- Alemtuzumab Injection [Campath]
-
Amsterdam, NetherlandsAmsterdam Medical Centre
Jun 20, 2023
Metastatic Melanoma, Skin Cancer Trial run by the National Cancer Institute (NCI) (drug, biological, radiation)
Active, not recruiting
- Metastatic Melanoma
- Skin Cancer
- Aldesleukin
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 24, 2022
Sickle Cell Disease, Hemoglobinopathies Trial in Nashville (drug, procedure, radiation)
Active, not recruiting
- Sickle Cell Disease
- Hemoglobinopathies
- Thymoglobulin
- +7 more
-
Nashville, TennesseeVanderbilt-Ingram Cancer Center
Dec 20, 2021
Stem Cell Transplantation, Rehabilitation Trial in Aarhus (Multimodal interdisciplinary rehabilitation programme (HAPPY))
Completed
- Stem Cell Transplantation
- Rehabilitation
- Multimodal interdisciplinary rehabilitation programme (HAPPY)
-
Aarhus, DenmarkDep. of Hem. Aarhus Universitetshospital
Nov 2, 2021
Sickle Cell Anemia, Beta Thalassemia Trial run by the NHLBI (radiation, drug, biological)
Recruiting
- Sickle Cell Anemia
- Beta Thalassemia
- TBI
- +6 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 26, 2023
Kidney Transplantation Trial in Baltimore, Livingston, New York (TCD601)
Recruiting
- Kidney Transplantation
- TCD601
-
San Francisco, California
- +4 more
Oct 28, 2022
Refractory Non Hodgkin Lymphoma, Relapsed Non Hodgkin Lymphoma Trial in Sacramento (biological, radiation, procedure, drug)
Active, not recruiting
- Refractory Non Hodgkin Lymphoma
- Relapsed Non Hodgkin Lymphoma
- rituximab
- +7 more
-
Sacramento, CaliforniaUniversity of California Davis
Nov 28, 2022
HPV 16+ Recurrent or Metastatic Cancer Trial (CD8 reduced peripheral blood cells taken from related donors vaccinated against
Not yet recruiting
- HPV 16+ Recurrent or Metastatic Cancer
- CD8 reduced peripheral blood cells taken from related donors vaccinated against HPV16
- Non-myeloablative allogeneic bone marrow transplant from related donors vaccinated against HPV16
- (no location specified)
Jun 27, 2022
Pleural Mesothelioma Trial in Toronto (Cyclophosphamide, Fludarabine, Autologous tumor infiltrating lymphocytes (TILs))
Completed
- Pleural Mesothelioma
- Cyclophosphamide
- +3 more
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Jan 8, 2023
B-Cell Lymphoid Malignancies, Hematologic Malignancy, Non-Hodgkin Lymphoma Trial in Miami (Hematopoietic Stem Cells from
Recruiting
- B-Cell Lymphoid Malignancies
- +2 more
- Hematopoietic Stem Cells from HLA-compatible Related
- Hematopoietic Stem Cells from HLA Unrelated
-
Miami, FloridaMiami Cancer Institute at Baptist Health of South Florida
May 5, 2022
Sickle Cell Disease Trial in Amsterdam (Engerix-B)
Recruiting
- Sickle Cell Disease
-
Amsterdam, NetherlandsAmsterdam Medical Centre
Jan 6, 2022
Sickle Cell Disease Trial in Chicago (Allogeneic Non-Myeloablative Stem Cell Transplantation, Alemtuzumab, Sirolimus)
Recruiting
- Sickle Cell Disease
- Allogeneic Non-Myeloablative Stem Cell Transplantation
- +2 more
-
Chicago, IllinoisUniversity of Illinois at Chicago
Feb 16, 2022
Acute Myeloid Leukemia, B-Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Stanford (biological, drug,
Completed
- Acute Myeloid Leukemia
- +6 more
- Anti-Thymocyte Globulin
- +5 more
-
Stanford, CaliforniaStanford University, School of Medicine
Jun 1, 2021
Myeloproliferative Disorders, Acute Myelogenous Leukemia, Chronic Myelogenous Leukemia Trial run by the NHLBI (T-cell replete
Completed
- Myeloproliferative Disorders
- +4 more
- T-cell replete PBPC allograft
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 12, 2022
Severe Aplastic Anemia, Bone Marrow Failure Syndromes Trial in Baltimore, Milwaukee (procedure, drug, radiation)
Completed
- Severe Aplastic Anemia
- Bone Marrow Failure Syndromes
- Bone marrow transplant
- +7 more
-
Baltimore, Maryland
- +1 more
Feb 10, 2022
Acute Leukemia, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia/Lymphoma Trial in Minneapolis (drug, radiation, biological)
Recruiting
- Acute Leukemia
- +24 more
- Fludarabine
- +6 more
-
Minneapolis, MinnesotaMasonic Cancer Center at University of Minnesota
Nov 4, 2021
Metastatic Urothelial Carcinoma Trial in Ramat Gan (Tumor Infiltrating Lymphocytes (TIL), Proleukin)
Recruiting
- Metastatic Urothelial Carcinoma
- Tumor Infiltrating Lymphocytes (TIL)
- Proleukin
-
Ramat Gan, IsraelSheba Medical Center
Feb 8, 2021
Kidney Transplantation Trial in United States (TCD601)
Not yet recruiting
- Kidney Transplantation
- TCD601
-
Chicago, Illinois
- +4 more
Jun 13, 2022
Tumor Metastasis Trial run by the NHLBI (methotrexate, Cyclosporin)
Terminated
- Neoplasm Metastasis
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Nov 8, 2021
Sickle Cell Disease, Sickle Cell Disorder, Hemoglobinopathies Trial in Duarte (Cyclophosphamide, Pentostatin, Rabbit
Recruiting
- Sickle Cell Disease
- +4 more
- Cyclophosphamide
- +5 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jul 6, 2022
Myelodysplastic Syndrome RAEB-I or RAEB-II, Refractory Acute Myeloid Leukemia, Refractory CML Myeloid Blast Crisis Trial in
Completed
- Myelodysplastic Syndrome RAEB-I or RAEB-II
- +2 more
- GM-CSF secreting leukemia vaccine
-
Boston, MassachusettsDana-Farber Cancer Institute
Jan 28, 2022